Dr. Hélène Karcher has 12 years of experience in quantitative methods applied to impact decisions in health care – as an academic, drug developer and consultant. She has used Monolix since its first version and followed its developments since then.
Hélène is currently a scientific consultant at LASER, a leader in population health sciences for real-world evidence generation, where she heads a group of highly-skilled modelers and statisticians.
Prior to joining LASER, Hélène contributed to the creation and expansion of the Novartis Modeling & Simulation group in the USA and in Switzerland. She received for this work the 2011 Pierre Faurre award for significant, innovative contributions to science and its translation in industry. During her 6 years at Novartis, Hélène also acted as scientific expert and project manager for the preclinical and clinical development of 14 new compounds in multiple indications.
Hélène holds a physics & engineering degree from Ecole Polytechnique, France and a PhD in systems biology from Massachusetts Institute of Technology, USA.